Suchergebnisse - "Alexander, John H"

PubPharm (33)

1

A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction

enthalten in: Circulation | 2022

von Rao, S. | Kirsch, B. | Bhatt, D. | +114

CommentIn: Circulation. 2022 Oct 18;146(16):1207-1209. - PMID 36030388

2

Apixaban or Warfarin and Aspirin or Placebo After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Patients With Atrial Fibrillation and Prior Stroke : A Post Hoc Analysis From the AUGUSTUS Trial

enthalten in: JAMA cardiology | 2022

von Bahit, M. | Vora, A. | Li, Z. | +15

3

Impact of prior oral anticoagulant use and outcomes on patients from secondary analysis in the AUGUSTUS trial

enthalten in: Open heart | 2022

von Welsh, R. | Dehghani, P. | Lopes, R. | +11

4

Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19 : The ACTIV-4B Randomized Clinical Trial

enthalten in: JAMA | 2021

von Connors, J. | Brooks, M. | Sciurba, F. | +80

CommentIn: JAMA. 2021 Nov 2;326(17):1685-1686. - PMID 34633417

5

Apixaban or Vitamin K Antagonists and Aspirin or Placebo According to Kidney Function in Patients With Atrial Fibrillation After Acute Coronary Syndrome or Percutaneous Coronary Intervention : Insights From the AUGUSTUS Trial

enthalten in: Circulation | 2021

von Hijazi, Z. | Alexander, J. | Li, Z. | +14

6

Individual Patient Data from the Pivotal Randomized Controlled Trials of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (COMBINE AF) : Design and Rationale: From the COMBINE AF (A Collaboration between Multiple institutions to Better Investigate Non-vitamin K antagonist oral anticoagulant use in Atrial Fibrillation) Investigators

enthalten in: American heart journal | 2021

von Carnicelli, A. | Hong, H. | Giugliano, R. | +15

7

Evaluation of the Age, Biomarkers, and Clinical History-Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials

enthalten in: JAMA network open | 2020

von Hijazi, Z. | Oldgren, J. | Lindbäck, J. | +13

CommentIn: JAMA Netw Open. 2020 Sep 1;3(9):e2016126. - PMID 32936295

8

Risk/Benefit Tradeoff of Antithrombotic Therapy in Patients With Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention : Insights From AUGUSTUS

enthalten in: Circulation | 2020

von Alexander, J. | Wojdyla, D. | Vora, A. | +7

CommentIn: Ann Intern Med. 2020 Sep 15;173(6):JC29. - PMID 32926823

9

Stent Thrombosis in Patients With Atrial Fibrillation Undergoing Coronary Stenting in the AUGUSTUS Trial

enthalten in: Circulation | 2020

von Lopes, R. | Leonardi, S. | Wojdyla, D. | +12

10

Hospitalization Among Patients With Atrial Fibrillation and a Recent Acute Coronary Syndrome or Percutaneous Coronary Intervention Treated With Apixaban or Aspirin : Insights From the AUGUSTUS Trial

enthalten in: Circulation | 2019

von Vora, A. | Alexander, J. | Wojdyla, D. | +17